Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease

Infliximab (Remicade), a chimeric monoclonal antibody to tumor necrosis factor‐alpha (anti–TNF‐α), is being used with increasing frequency in the treatment of Crohn's disease. Infliximab's safety profile to date has been good with reported adverse events being mild to moderate. We report a...

Full description

Saved in:
Bibliographic Details
Published in:Inflammatory bowel diseases 2004-05, Vol.10 (3), p.274-277
Main Authors: Panagi, Sofia, Palka, Wojciech, Korelitz, Burton I., Taskin, Metin, Lessnau, Klaus D.
Format: Article
Language:English
Subjects:
Adult
alveolar hemorrhage
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Crohn Disease - drug therapy
Female
Gastrointestinal Agents - adverse effects
Gastrointestinal Agents - therapeutic use
Hemorrhage - chemically induced
Humans
Infliximab
infliximab Crohn's disease
Pneumonia - chemically induced
Pneumonia - diagnosis
Pulmonary Alveoli - pathology
Tomography, X-Ray Computed
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 277
container_issue 3
container_start_page 274
container_title Inflammatory bowel diseases
container_volume 10
creator Panagi, Sofia
Palka, Wojciech
Korelitz, Burton I.
Taskin, Metin
Lessnau, Klaus D.
description Infliximab (Remicade), a chimeric monoclonal antibody to tumor necrosis factor‐alpha (anti–TNF‐α), is being used with increasing frequency in the treatment of Crohn's disease. Infliximab's safety profile to date has been good with reported adverse events being mild to moderate. We report a case of diffuse alveolar hemorrhage after the second infliximab infusion in a patient with Crohn's disease. The mechanism by which infliximab may have caused the observed pulmonary insult remains unknown. Physicians should be aware of the possible association between infliximab treatment and the development of alveolar hemorrhage. Future cases should be reported.
doi_str_mv 10.1097/00054725-200405000-00016
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_902337058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>902337058</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2316-ac232a22beadca69103584ce9adc2c907c1fafe492b19ca2248630f1862d76133</originalsourceid><addsrcrecordid>eNpFkMlOwzAQhi0EoqXwCii3ngLjJYl9hJSlUiUucLacZEyDshQ7Afr2GNqCRqPZPo30_4REFK4oqOwaABKRsSRmAAKSMMYhaXpEpjThaSykEMehh0zGoJSckDPv3wBYCHVKJjRhChQTU7Jc1NaOHiPTfGDfGBetse2dW5vXsLMDuqjubFN_1a0posGhGVrshqi3Ue76dTf3UVV7NB7PyYk1jceLfZ2Rl_u75_wxXj09LPObVbxhnKaxKRlnhrECTVWaVFHgiRQlqjCyUkFWUmssCsUKqsoACplysFSmrMpSyvmMzHd_N65_H9EPuq19iU1jOuxHrxUwzjNIZCAv9-RYtFjpjQsi3FYf1Acg3wGfdYPb_zvoH5f1wWX957L-dVkvbxc8k0ABgiL-Ddqsb24</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902337058</pqid></control><display><type>article</type><title>Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease</title><source>Oxford Journals Online</source><creator>Panagi, Sofia ; Palka, Wojciech ; Korelitz, Burton I. ; Taskin, Metin ; Lessnau, Klaus D.</creator><creatorcontrib>Panagi, Sofia ; Palka, Wojciech ; Korelitz, Burton I. ; Taskin, Metin ; Lessnau, Klaus D.</creatorcontrib><description>Infliximab (Remicade), a chimeric monoclonal antibody to tumor necrosis factor‐alpha (anti–TNF‐α), is being used with increasing frequency in the treatment of Crohn's disease. Infliximab's safety profile to date has been good with reported adverse events being mild to moderate. We report a case of diffuse alveolar hemorrhage after the second infliximab infusion in a patient with Crohn's disease. The mechanism by which infliximab may have caused the observed pulmonary insult remains unknown. Physicians should be aware of the possible association between infliximab treatment and the development of alveolar hemorrhage. Future cases should be reported.</description><identifier>ISSN: 1078-0998</identifier><identifier>EISSN: 1536-4844</identifier><identifier>DOI: 10.1097/00054725-200405000-00016</identifier><identifier>PMID: 15290924</identifier><language>eng</language><publisher>Philadelphia: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Adult ; alveolar hemorrhage ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - therapeutic use ; Crohn Disease - drug therapy ; Female ; Gastrointestinal Agents - adverse effects ; Gastrointestinal Agents - therapeutic use ; Hemorrhage - chemically induced ; Humans ; Infliximab ; infliximab Crohn's disease ; Pneumonia - chemically induced ; Pneumonia - diagnosis ; Pulmonary Alveoli - pathology ; Tomography, X-Ray Computed</subject><ispartof>Inflammatory bowel diseases, 2004-05, Vol.10 (3), p.274-277</ispartof><rights>Copyright © 2004 Crohn's &amp; Colitis Foundation of America, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15290924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Panagi, Sofia</creatorcontrib><creatorcontrib>Palka, Wojciech</creatorcontrib><creatorcontrib>Korelitz, Burton I.</creatorcontrib><creatorcontrib>Taskin, Metin</creatorcontrib><creatorcontrib>Lessnau, Klaus D.</creatorcontrib><title>Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease</title><title>Inflammatory bowel diseases</title><addtitle>Inflamm Bowel Dis</addtitle><description>Infliximab (Remicade), a chimeric monoclonal antibody to tumor necrosis factor‐alpha (anti–TNF‐α), is being used with increasing frequency in the treatment of Crohn's disease. Infliximab's safety profile to date has been good with reported adverse events being mild to moderate. We report a case of diffuse alveolar hemorrhage after the second infliximab infusion in a patient with Crohn's disease. The mechanism by which infliximab may have caused the observed pulmonary insult remains unknown. Physicians should be aware of the possible association between infliximab treatment and the development of alveolar hemorrhage. Future cases should be reported.</description><subject>Adult</subject><subject>alveolar hemorrhage</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Crohn Disease - drug therapy</subject><subject>Female</subject><subject>Gastrointestinal Agents - adverse effects</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Hemorrhage - chemically induced</subject><subject>Humans</subject><subject>Infliximab</subject><subject>infliximab Crohn's disease</subject><subject>Pneumonia - chemically induced</subject><subject>Pneumonia - diagnosis</subject><subject>Pulmonary Alveoli - pathology</subject><subject>Tomography, X-Ray Computed</subject><issn>1078-0998</issn><issn>1536-4844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpFkMlOwzAQhi0EoqXwCii3ngLjJYl9hJSlUiUucLacZEyDshQ7Afr2GNqCRqPZPo30_4REFK4oqOwaABKRsSRmAAKSMMYhaXpEpjThaSykEMehh0zGoJSckDPv3wBYCHVKJjRhChQTU7Jc1NaOHiPTfGDfGBetse2dW5vXsLMDuqjubFN_1a0posGhGVrshqi3Ue76dTf3UVV7NB7PyYk1jceLfZ2Rl_u75_wxXj09LPObVbxhnKaxKRlnhrECTVWaVFHgiRQlqjCyUkFWUmssCsUKqsoACplysFSmrMpSyvmMzHd_N65_H9EPuq19iU1jOuxHrxUwzjNIZCAv9-RYtFjpjQsi3FYf1Acg3wGfdYPb_zvoH5f1wWX957L-dVkvbxc8k0ABgiL-Ddqsb24</recordid><startdate>200405</startdate><enddate>200405</enddate><creator>Panagi, Sofia</creator><creator>Palka, Wojciech</creator><creator>Korelitz, Burton I.</creator><creator>Taskin, Metin</creator><creator>Lessnau, Klaus D.</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>200405</creationdate><title>Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease</title><author>Panagi, Sofia ; Palka, Wojciech ; Korelitz, Burton I. ; Taskin, Metin ; Lessnau, Klaus D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2316-ac232a22beadca69103584ce9adc2c907c1fafe492b19ca2248630f1862d76133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>alveolar hemorrhage</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Crohn Disease - drug therapy</topic><topic>Female</topic><topic>Gastrointestinal Agents - adverse effects</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Hemorrhage - chemically induced</topic><topic>Humans</topic><topic>Infliximab</topic><topic>infliximab Crohn's disease</topic><topic>Pneumonia - chemically induced</topic><topic>Pneumonia - diagnosis</topic><topic>Pulmonary Alveoli - pathology</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Panagi, Sofia</creatorcontrib><creatorcontrib>Palka, Wojciech</creatorcontrib><creatorcontrib>Korelitz, Burton I.</creatorcontrib><creatorcontrib>Taskin, Metin</creatorcontrib><creatorcontrib>Lessnau, Klaus D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Inflammatory bowel diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Panagi, Sofia</au><au>Palka, Wojciech</au><au>Korelitz, Burton I.</au><au>Taskin, Metin</au><au>Lessnau, Klaus D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease</atitle><jtitle>Inflammatory bowel diseases</jtitle><addtitle>Inflamm Bowel Dis</addtitle><date>2004-05</date><risdate>2004</risdate><volume>10</volume><issue>3</issue><spage>274</spage><epage>277</epage><pages>274-277</pages><issn>1078-0998</issn><eissn>1536-4844</eissn><abstract>Infliximab (Remicade), a chimeric monoclonal antibody to tumor necrosis factor‐alpha (anti–TNF‐α), is being used with increasing frequency in the treatment of Crohn's disease. Infliximab's safety profile to date has been good with reported adverse events being mild to moderate. We report a case of diffuse alveolar hemorrhage after the second infliximab infusion in a patient with Crohn's disease. The mechanism by which infliximab may have caused the observed pulmonary insult remains unknown. Physicians should be aware of the possible association between infliximab treatment and the development of alveolar hemorrhage. Future cases should be reported.</abstract><cop>Philadelphia</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>15290924</pmid><doi>10.1097/00054725-200405000-00016</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1078-0998
ispartof Inflammatory bowel diseases, 2004-05, Vol.10 (3), p.274-277
issn 1078-0998
1536-4844
language eng
recordid cdi_proquest_miscellaneous_902337058
source Oxford Journals Online
subjects Adult
alveolar hemorrhage
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Crohn Disease - drug therapy
Female
Gastrointestinal Agents - adverse effects
Gastrointestinal Agents - therapeutic use
Hemorrhage - chemically induced
Humans
Infliximab
infliximab Crohn's disease
Pneumonia - chemically induced
Pneumonia - diagnosis
Pulmonary Alveoli - pathology
Tomography, X-Ray Computed
title Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T19%3A42%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diffuse%20alveolar%20hemorrhage%20after%20infliximab%20treatment%20of%20Crohn's%20disease&rft.jtitle=Inflammatory%20bowel%20diseases&rft.au=Panagi,%20Sofia&rft.date=2004-05&rft.volume=10&rft.issue=3&rft.spage=274&rft.epage=277&rft.pages=274-277&rft.issn=1078-0998&rft.eissn=1536-4844&rft_id=info:doi/10.1097/00054725-200405000-00016&rft_dat=%3Cproquest_pubme%3E902337058%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p2316-ac232a22beadca69103584ce9adc2c907c1fafe492b19ca2248630f1862d76133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=902337058&rft_id=info:pmid/15290924&rfr_iscdi=true